Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China)
One of the promising areas in the development of innovative products for the treatment of cancer is the use of oncolytic (native or genetically modified) viruses (OLVs) for selective targeting of tumour cells and their destruction, especially as part of combination therapy. At present, there are thr...
Saved in:
| Main Authors: | E. V. Melnikova, O. A. Rachinskaya, V. A. Merkulov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2021-10-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01) -
Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01) -
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
by: Xiaoli Zhou, et al.
Published: (2025-11-01) -
Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01) -
Russian regulatory system for clinical trials is consistent with international approaches
by: Yu. N. Linkova
Published: (2023-12-01)